GlassScriptPhysician profile
Bryan V Pham
NPI 1336406859
$12,490.22
in general payments reported to CMS, 2019-2025
56 companies · $1,252 in 2025
The $1,252 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $657 · 2020: $408 · 2021: $1,567 · 2022: $2,664 · 2023: $3,013 · 2024: $2,930 · 2025: $1,252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,139 · Education: $55.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,138.71 |
| Education | $55.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,823.33 | 2021-2025 | |
| Ucb, INC. | $857.29 | 2019-2025 | Nayzilam, Briviact, Rystiggo |
| Biogen, INC. | $796.59 | 2020-2025 | Vumerity, Tysabri, Tysabri |
| Lilly USA, LLC | $748.09 | 2019-2024 | Amyvid, Emgality, Reyvow |
| Novartis Pharmaceuticals Corporation | $674.55 | 2019-2025 | |
| Emd Serono, INC. | $659.18 | 2022-2024 | Mavenclad |
| Argenx US, INC. | $586.92 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Amgen INC. | $568.68 | 2019-2025 | Uplizna, Tepezza, Aimovig |
| Lundbeck LLC | $496.67 | 2021-2025 | Vyepti |
| Genzyme Corporation | $427.51 | 2019-2025 | |
| Sk Life Science, INC. | $414.84 | 2020-2024 | Xcopri |
| Neurelis, INC. | $397.79 | 2021-2025 | Valtoco |
| Eisai INC. | $363.51 | 2019-2024 | |
| Alexion Pharmaceuticals, INC. | $343.35 | 2021-2025 | Ultomiris |
| Biohaven Pharmaceuticals, INC. | $316.64 | 2021 |
Show all 56 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.